Quanticate, a global data-focused CRO, is expanding its capabilities in India with the opening of a new office in Bangalore.
“Expansion of our facility in India is in direct response to the requirements of our customers and the driving force that enabled us to significantly grow in this region,” explained Daniel Chapple, executive vice president and chief commercial officer, Quanticate. “Research has shown that customers turn to Quanticate because of our experience, knowledge and the high quality that we offer. Now through this expansion, our customers will also benefit from even more cost effective offerings, particularly with the large-scale FSP’s that we have in place.”
India, along with other lower cost locations, have become integral to the greater adoption of outsourcing approaches especially since price remains one key consideration in the decision making process. However, ensuring that the operational structure keeps overall costs at an optimal level when taking into account oversight, communication and quality control at both the CRO and customer side, is a critical element to successfully provide support and solutions to the pharmaceutical, biotechnology, device and nutrition industries, according to Quanticate.
“Quanticate has been careful in its approach to using lower cost regions and does so for more than the purpose of achieving more attractive labor rates,” said Karen Oooms, executive vice president of operations, Quanticate. “We anticipate that all our locations will continue to grow based upon our healthy pipeline.”
Ooms added, “This is an exciting time at Quanticate as we have recently launched our centralized data solution and have been adding new expertise and technologies to support both our customers and our growing number of highly skilled statisticians, programmers, data managers, medical writers and pharmacovigilance experts.”